Page last updated: 2024-08-25

rosiglitazone and 6-cyano-7-nitroquinoxaline-2,3-dione

rosiglitazone has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, KC; Kilgore, MW; Pancani, T; Phelps, JT; Porter, NM; Searcy, JL; Thibault, O1

Other Studies

1 other study(ies) available for rosiglitazone and 6-cyano-7-nitroquinoxaline-2,3-dione

ArticleYear
Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.
    Journal of neurochemistry, 2009, Volume: 109, Issue:6

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium; Calcium Channels; Calcium Signaling; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Embryo, Mammalian; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Antagonists; Female; Hippocampus; Hypoglycemic Agents; Neuroglia; Neurons; Patch-Clamp Techniques; Pioglitazone; PPAR gamma; Pregnancy; Protein Binding; Rats; Receptors, N-Methyl-D-Aspartate; Rosiglitazone; Thiazolidinediones; Time Factors

2009